Speciality Medicines IPO Final Subscription Status
Final subscription data from BSE & NSE with category-wise breakdowns
Subscription (Shares)
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 21,000 | 20,21,000 | 96.24 |
| NII | 10,89,000 | 21,94,000 | 2.01 |
| bNII (>10 Lakh) | 7,26,000 | 19,63,000 | 2.70 |
| sNII (2-10 Lakh) | 3,63,000 | 2,31,000 | 0.64 |
| Retail | 10,90,000 | 9,22,000 | 0.85 |
| TOTAL | 22,00,000 | 51,37,000 | 2.34 |
Application Breakup
| Category | Reserved | Applications | Times |
|---|---|---|---|
| NII | 363 | 1,097 | 3.02 |
| bNII (>10 Lakh) | 242 | 196 | 0.81 |
| sNII (2-10 Lakh) | 121 | 116 | 0.96 |
| Retail | 545 | 461 | 0.85 |
| TOTAL | 1,271 | 1,870 | 1.47 |
Subscription (Crores)
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIB | 0.26 | 25.06 | 96.24 |
| NII | 13.50 | 27.21 | 2.01 |
| bNII (>10 Lakh) | 9.00 | 24.34 | 2.70 |
| sNII (2-10 Lakh) | 4.50 | 2.86 | 0.64 |
| Retail | 13.52 | 11.43 | 0.85 |
| TOTAL | 27.28 | 63.70 | 2.34 |
Day-wise Subscription
End-of-day subscription.
| Day | QIB | NII | bNII | sNII | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 20 Mar | 1.00x | 1.60x | 2.37x | 0.06x | 0.07x | 0.84x |
| Day 2 23 Mar | 1.00x | 1.82x | 2.68x | 0.10x | 0.19x | 1.00x |
| Day 3 24 Mar | 96.24x | 2.01x | 2.70x | 0.64x | 0.85x | 2.34x |
Estimated Allotment Chance
How Speciality Medicines’ demand compares with recent SME IPOs
Final multiples against the 192 SME IPOs listed in the last 12 months.
| Category | Speciality Medicines | SME median | Higher than |
|---|---|---|---|
| Overall | 2.34x | 4.03x | 40% of 192 |
| QIB | 96.24x | 14.69x | 75% of 163 |
| NII (HNI) | 2.01x | 5.36x | 33% of 192 |
| Retail | 0.85x | 3.58x | 11% of 192 |
Of the 88 recent SME IPOs that finished under 3x subscribed, 32% opened above the issue price, with a median listing-day move of +0%. Speciality Medicines itself listed at +0%.
Speciality Medicines IPO Subscription — Detailed Analysis
Where Speciality Medicines Subscription Finished
Speciality Medicines IPO was subscribed 2.34 times overall by the close of bidding — fully covered, indicating decent investor interest.
Speciality Medicines IPO Subscription — FAQs
See also: reading the subscription table · allotment chances · allotment process
Explore More
Quick links to all IPO sections